UniSuper Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
UniSuper Management's BIIB Position: Q3 2026 in Review
UniSuper Management increased its Biogen (BIIB) stake by 7.8% in Q3 2026, buying an estimated $276K and bringing the position to 18,029 shares worth $4.07M. The position accounts for 0.02% of the portfolio, ranked #337.
UniSuper Management first reported a position in BIIB in Q2 2023 and has held it in 14 quarters since. The position peaked at $18.3M in Q2 2023. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- UniSuper Management held 18,029 shares of Biogen worth $4.07M as of Q3 2026.
- UniSuper Management bought 1,300 Biogen shares in Q3 2026, an estimated $276K.
- Biogen made up 0.02% of UniSuper Management's portfolio in Q3 2026, its #337 holding.
- UniSuper Management first reported a position in Biogen in Q2 2023 and has held it in 14 quarters since.
- UniSuper Management's Biogen position peaked at $18.3M in Q2 2023.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on UniSuper Management's 13F filing for Q3 2026, filed 26 Oct 2026.